NeoClone

NeoClone, LLC excels in the production of monoclonal antibodies. Using its proprietary retroviral proach in the development process, NeoClone can produce high affinity antibodies in significantly less time and at a dramatically lower cost than the rest of the industry. NeoClone is currently servicing the reagent and diagnostic markets and is enhancing its proprietary process to provide services to the therapeutic market.